Vladimir Sergeevich Trifanov

Vladimir Sergeevich Trifanov

Auto-generated profile, based on publicly available information

Vladimir Sergeevich Trifanov

P.A. Hertsen Moscow Oncology Research Institute – branch of National Medical Radiology Research Center, Ministry of Health of Russia

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2025 in Annals of Critical Care
Verified
Journal Article
Open access
PDF file
VKVictoria E. Khoronenko
Victoria E. Khoronenko
IKIulia S. Koroleva
Iulia S. Koroleva
ВТВладимир Сергеевич Трифанов
Владимир Сергеевич Трифанов
ВХВиктория Эдуардовна Хороненко
Виктория Эдуардовна Хороненко
INTRODUCTION: Inadequate anaesthetic protection during surgery as well as poor control of postoperative pain are the trigger mechanisms of the surgical stress response, which represents a complex of homeostatic changes that significantly contribute to the development of postoperative complications. OBJECTIVE: The primary objective of this study was to summarize the current data on modern approaches to perioperative analgesia and protection of patients from surgical stress response during major abdominal surgeries. MATERIALS AND METHODS: The review includes sources which meet the objectives of the study and are indexed in the databases of PubMed, Google Scholar, MEDLINE, and eLibrary (for Russian authors). RESULTS: The analysis of the literature clearly identified the risk factors for the development of acute postoperative pain and demonstrated a trend towards combining postoperative analgesic methods. These approaches reduce the need for opioids, effectively modulate in the perioperative period stress response to surgical intervention, and decrease the risk of postoperative complications in abdominal surgery. CONCLUSIONS: Modern approaches to perioperative analgesia when used in a timely and appropriate manner are largely responsible for ensuring adequate patient protection. The trend towards decreasing opioid use during perioperative period suggests the combination of various techniques. Epidural analgesia (EA), erector spinae plane (ESP), quadratus lumborum (QLB), or transversus abdominis plane (TAP) blocks, intravenous lidocaine infusion, and nefopam are effective and complementary components of multimodal perioperative pain management.

23 April 2024 in P.A. Herzen Journal of Oncology
Verified
Journal Article
Closed access
MTM.M. Trandofilov
M.M. Trandofilov
VTV.S. Trifanov
V.S. Trifanov
NGN.A. Grishin
N.A. Grishin
Anatoly Yurievich PopovAnatoly Yurievich Popov
Anatoly Yurievich Popov
SKS.V. Kostirev
S.V. Kostirev
STS.G. Teryasov
S.G. Teryasov
Objective. Analysis of the results of treatment of patients with metastatic liver tumors using laser ablation. Material and methods. Results of treatment of 27 patients with metastatic liver lesions who underwent laser ablation for the period from March, 2017 to January 2023, were analyzed. The size of lesions was 10—40 mm, average size — 29.8±1.7 mm). Laser destruction was performed percutaneously, with laparoscopic and open approaches under ultrasound scanning in real time mode. For laser ablation, an ECHO LASER X4 device (Italy) was used. Ultrasound, MRI and CT with intravenous contrast were used for the dynamically control of ablation effectiveness. Results. In the early postoperative period, in one case, the formation of a subcapsular hematoma was observed in the area of the light guide, which did not require surgical intervention. The average bed/day was 4 days. One-year overall survival stood at 88%, two-year overall survival stood at 71%, 3-years — 43.5%. Conclusion. The use of laser ablation is indicated for insufficient functional liver volume in patients with previously extensive liver resections, and in somatically burdened patients who cannot undergo liver resection.

1 February 2018 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
OKOleg Ivanovich Kit
Oleg Ivanovich Kit
EFElena Frantsiyants
Elena Frantsiyants
LKLarisa S. Kozlova
Larisa S. Kozlova
VBValeria A. Bandovkina
Valeria A. Bandovkina
EKEvgeniy N. Kolesnikov
Evgeniy N. Kolesnikov
VTVladimir Trifanov
Vladimir Trifanov
258 Background: Our purpose was to study the protease/protease inhibitor (P/PI) balance in the blood plasma of patients with cancer of the head of the pancreas before and after pancreatoduodenal resection (PDR) with postoperative complications. Methods: The study was performed using clinical observation, biochemical examinations and statistical analysis in Microsoft Office Excel 2010. The blood plasma of 92 patients with pancreatic head cancer (53 men and 39 women aged 45-76 years, Т2-4N0M0) was studied before the surgery (b/s) and on days 1, 7, 14 and 17 after PDR. The patients were divided into two groups: g1 – 69 patients without postoperative (p/o) complications and g2 – 23 patients with p/o complications: generalization – 7, thrombosis - 8, acute postoperative pancreatitis - 2, gastrostasis - 2, anastomotic leakage - 4 patients. Kinetics of trypsin-like proteases (TLP) and α-1-proteinase inhibitor (α1PI) was studied by spectrophotometry. The data were compared with the blood plasma of 39 healthy donors (N). Results: TLP activity b/s exceeded N in g1 and g2 by 4.1 and 10.6 times; TLP in g2 was 2.6 times higher than in g1. The α1PI activity b/s was higher than N by 1.2 times (p < 0.05) in g1 and lower than N by 2.0 times in g2; α1PI in g2 was 2.4 times lower than in g1. After PDR, activity of TLP increased in all patients on day 1 but decreased on days 7-14 in g1 remaining 2.7 times higher than N by the discharge. The TLP activity in g2 by the discharge was similar to levels b/s and exceeded g1 by 4.4 and N by 12.1 times. The α1PI activity after PDR increased in all patients on days 1-17, but in g1 by the discharge it was similar to N and in g2 it was 1.5 times lower than N. The TLP/α1PI ratio was higher in g2 than in g1 at all times. Conclusions: A high TLP activity and a low α1PI activity, compared to N, were maintained in the blood plasma of all patients with p/o complications, despite their types. The P/PI balance in g2 was shifted to the left being 5.5-9.0 times higher than in g1 at all times which allowed the prognosis of postoperative complications before the surgery, perioperatively or on day 1 after the surgery.

11 April 2025 in Life
Verified
Journal Article
Open access
PDF file
MPMikhail Potievskiy
Mikhail Potievskiy
LNLidia A. Nekrasova
Lidia A. Nekrasova
IKIvan V. Korobov
Ivan V. Korobov
EBEkaterina A. Bykova
Ekaterina A. Bykova
RMRuslan I. Moshurov
Ruslan I. Moshurov
AKAndrei Kaprin
Andrei Kaprin
Pancreatic cancer is a tumor with a poor prognosis, and improving its survival outcomes remains a formidable challenge, requiring a multidisciplinary approach that integrates innovative surgical and pharmacological strategies, guided by molecular and genetic insights. The pathomorphological and genetic characteristics of pancreatic cancer, reflected in morphological, immunohistochemical, and serological marker expression, reveal key patterns of tumor genotypic changes during carcinogenesis, aiding in prognostic evaluation and clinical strategy development. The mutational profile of pancreatic tumors is quite heterogeneous and diverse in terms of mutated genes, including in relation to morphological subtypes, but certain patterns have been identified as a result of studies. Pancreatic adenocarcinoma, for instance, is frequently driven by mutations regulating cell division (KRAS). The disease prognosis often depends on the morphological subtype and tumor microenvironment. Neuroendocrine tumors of the pancreas are characterized by a number of pathogenetic features that distinguish them from adenocarcinomas. Thus, neuroendocrine tumors are characterized by mutations of the MENIN protein, which prevents cells from entering the mitosis phase by stimulating the expression of cell cycle regulators. Thus, epithelial and neuroendocrine malignancies of the pancreas differ in immunohistochemical and genetic features, but there are similar mechanisms of pathogenesis, such as BRCA1 and BRCA2 gene mutations, impaired expression of p53 antioncogene, and HIF-2α and mTOR receptor mutations. The predictive impact of serological markers, such as CA 19-9 and CEA, offers insights into tumor metastasis and long-term outcomes, emphasizing the need for personalized therapeutic strategies. Tailoring treatments based on individual molecular profiles holds promise for improving prognosis, as the genetic landscape of pancreatic tumors varies significantly between patients. This underscores the importance of a systematic, patient-specific approach that addresses tumor heterogeneity, resistance mechanisms, and the molecular underpinnings of carcinogenesis.

31 December 2025 in Russian Journal of Anesthesiology and Reanimatology
Verified
Journal Article
Closed access
YKYu.S. Koroleva
Yu.S. Koroleva
VKV.E. Khoronenko
V.E. Khoronenko
VTV.S. Trifanov
V.S. Trifanov
The problem of perioperative analgesia for extensive abdominal surgeries remains relevant, as available experience of widespread epidural analgesia revealed limitations and complexities of this approach. Objective. To compare the efficacy and safety of perioperative thoracic epidural analgesia and nefopam therapy (opioid-sparing strategy), and to analyze the impact of analgesia methods on postoperative complications. Material and methods. The study included 60 patients with biliopancreatoduodenal tumors who underwent (gastro)pancreatoduodenectomy (G(PDD)). Patients were randomized into 2 groups: the nefopam group (N, n=30) and the epidural analgesia group (EA, n=30). We assessed course of anesthesia, NRS scores of postoperative pain syndrome at rest and during mobilization, serum glucose and cortisol at different stages of follow-up, opioid requirements, onset of peristalsis and first defecation, postoperative complications. Results. Pain syndrome was less severe in the group N on days 1 and 2 after surgery (p=0.012 and p=0.045). After 2 and 3 days, the need for morphine was significantly lower in group N, where mean dose was 14.42 (95% CI 12.30—16.54) mg/day and 8.60 (95% CI 6.05—11.15) mg/day. In the group EA, these values were 19.33 (95% CI 15.41—23.26) mg/day and 13.92 (95% CI 10.58—17.26) mg/day, respectively (p=0.029 and p=0.012). Independent predictors of pancreatic fistula were high BMI, intraoperative blood loss and postoperative infusion volume. Conclusion. Both techniques allow for adequate pain control after pancreaticoduodenectomy. Nefopam has higher opioid-sparing effect in postoperative period. The impact of perioperative analgesia technique on postoperative complications after pancreaticoduodenectomy requires further investigation.

13 March 2024 in Pirogov Russian Journal of Surgery
Verified
Journal Article
Closed access
VKV.E. Khoronenko
V.E. Khoronenko
VTV.S. Trifanov
V.S. Trifanov
NCNatalia V. Chebotareva
Natalia V. Chebotareva
MMM.YU. Meshcheryakova
M.YU. Meshcheryakova
MKM.V. Kosogolov
M.V. Kosogolov
McKittrick-Wheelock syndrome is a rare disease when villous adenoma of the distal colon predisposes to profuse watery diarrhea with subsequent severe electrolyte disturbances and acute renal damage. A differentiated approach to correct diagnosis requires in-depth pathophysiological knowledge of regulation of water-electrolyte metabolism, functional and organic disorders of gastrointestinal tract and clinical manifestations of hypoosmolar dehydration. The peculiarity of the McKittrick-Wheelock syndrome is a 100% probability of death without treatment and complete regression of symptoms under complex correction of homeostasis and total resection of tumor. We demonstrate the main clinical trends of the McKittrick-Wheelock syndrome. This report may be useful for general practitioners, gastroenterologists, oncologists, nephrologists and anesthesiologists.